Increased use of rapid diagnostic techniques such as PCR may allow prompt discontinuation of vancomycin when not indicated. Further development of alternative antimicrobials may also lessen its use.

Aims: To analyze the results from the clinical monitoring of serum vancomycin levels among ICU pediatric patients. Methods: A retrospective drug utilization evaluation was performed for pediatric ...

Sandia National Laboratories has created a wearable sensor patch that uses microneedles and nanoscale sensors to continuously monitor the antibiotic vancomycin, offering real-time measurements and ...

Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic drug vancomycin. Common symptoms consist of a rash that itches during or after the infusion of vancomycin. VFS is the most common ...

Additional room temperature stable Vancomycin Injection Premix doses now approved in the US, and available in October 2020 Doses of 1.25 g, 1.75 g and 750 mg ready-to-use Vancomycin premixes In total, ...

Until we have peer-reviewed publication of a prospective trial showing superiority of alternatives to vancomycin, its use will continue. The intent of the guidelines was to optimize vancomycin dosing ...